Humacyte HUMA will release its quarterly earnings report on Friday, 2024-11-08. Here's a brief overview for investors ahead of the announcement.
Analysts anticipate Humacyte to report an earnings per share (EPS) of $-0.25.
The market awaits Humacyte's announcement, with hopes high for news of surpassing estimates and providing upbeat guidance for the next quarter.
It's important for new investors to understand that guidance can be a significant driver of stock prices.
Performance in Previous Earnings
During the last quarter, the company reported an EPS missed by $0.03, leading to a 9.62% drop in the share price on the subsequent day.
Here's a look at Humacyte's past performance and the resulting price change:
| Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|
| EPS Estimate | -0.24 | -0.22 | -0.24 | -0.25 |
| EPS Actual | -0.27 | -0.29 | -0.24 | -0.25 |
| Price Change % | -10.0% | 4.0% | -8.0% | 6.0% |
Humacyte Share Price Analysis
Shares of Humacyte were trading at $5.43 as of November 06. Over the last 52-week period, shares are up 127.44%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.
To track all earnings releases for Humacyte visit their earnings calendar on our site.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
